Gram-positive bacteria have different susceptibilities to the host-derived antimicrobial lysophosphatidylcholine and adapt to lysophosphatidylcholine-induced stress via distinct mechanisms

The human lipid metabolites, lysophosphatidylcholine (LPC) and plasmenyl-LPC (pLPC), modulate both the metabolic health status and innate immunity of an individual. Previous studies reported direct antibacterial activity of LPC, while pLPC has not been evaluated. Meanwhile, some bacteria harvest LPC for producing phosphatidylcholine (PC); others produce plasmalogens under anaerobic conditions. These discoveries suggest that both LPC and pLPC can mediate host-microbe interactions. In this study, we demonstrated diverse susceptibility profiles of human pathobionts to LPC(18:0) and pLPC(18:0) at physiologically-relevant concentrations. Though the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa were not susceptible to LPC or pLPC, all tested Gram-positive bacteria, including Staphylococcus aureus , Streptococcus agalactiae , Enterococcus faecalis , and E. faecium were susceptible to pLPC, suggesting robust antimicrobial activity of this lipid in vivo . While LPC can effectively kill S. aureus and S. agalactiae , it does not completely inhibit the growth of enterococci. Moreover, pretreatment of LPC-containing medium with E. faecalis rescues S. agalactiae from LPC killing, suggesting that E. faecalis deactivates LPC extracellularly and can protect co-resident LPC-sensitive pathobionts. Finally, we observed the emergence of spontaneous LPC-resistant S. aureus. These strains have point mutations in sensor kinase gene walK and the lipid metabolism genes fabF and farR , which lead to increased expression of the efflux pump gene farE . Collectively, these results support the antibacterial effects of LPC and pLPC and indicate distinct bacterial adaptation mechanisms, providing novel insights on lipid-mediated host-bacterial interactions.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.17.767358
Primary Topic
Antimicrobial agents and applications
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Gram-positive bacteria have different susceptibilities to the host-derived antimicrobial lysophosphatidylcholine and adapt to lysophosphatidylcholine-induced stress via distinct mechanisms

Guan Hao Chen, Yahan Wei, Kelli L. Palmer, C. R. Upreti et al.
bioRxiv (Cold Spring Harbor Laboratory)
Antimicrobial agents and applications
preprint

Gram-positive bacteria have different susceptibilities to the host-derived antimicrobial lysophosphatidylcholine and adapt to lysophosphatidylcholine-induced stress via distinct mechanisms

Guan Hao Chen, Yahan Wei, Kelli L. Palmer, C. R. Upreti, Julie Nguyen, Ziqiang Guan, Priya M. Christensen, Savannah E. Pas, Lily E Tillett, Gayatri Chandrasenan
preprint en

Abstract

The human lipid metabolites, lysophosphatidylcholine (LPC) and plasmenyl-LPC (pLPC), modulate both the metabolic health status and innate immunity of an individual. Previous studies reported direct antibacterial activity of LPC, while pLPC has not been evaluated. Meanwhile, some bacteria harvest LPC for producing phosphatidylcholine (PC); others produce plasmalogens under anaerobic conditions. These discoveries suggest that both LPC and pLPC can mediate host-microbe interactions. In this study, we demonstrated diverse susceptibility profiles of human pathobionts to LPC(18:0) and pLPC(18:0) at physiologically-relevant concentrations. Though the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa were not susceptible to LPC or pLPC, all tested Gram-positive bacteria, including Staphylococcus aureus , Streptococcus agalactiae , Enterococcus faecalis , and E. faecium were susceptible to pLPC, suggesting robust antimicrobial activity of this lipid in vivo . While LPC can effectively kill S. aureus and S. agalactiae , it does not completely inhibit the growth of enterococci. Moreover, pretreatment of LPC-containing medium with E. faecalis rescues S. agalactiae from LPC killing, suggesting that E. faecalis deactivates LPC extracellularly and can protect co-resident LPC-sensitive pathobionts. Finally, we observed the emergence of spontaneous LPC-resistant S. aureus. These strains have point mutations in sensor kinase gene walK and the lipid metabolism genes fabF and farR , which lead to increased expression of the efflux pump gene farE . Collectively, these results support the antibacterial effects of LPC and pLPC and indicate distinct bacterial adaptation mechanisms, providing novel insights on lipid-mediated host-bacterial interactions.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), The University of Texas at Dallas (US), Duke University (US), The University of Texas Rio Grande Valley (US), University of North Texas at Dallas (US)
Antimicrobial agents and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon